Chromadex CORP DEF 14A proxy statements

Niagen Bioscience, Inc. will hold its annual shareholder meeting on June 24, 2025, to vote on director elections, auditor ratification, executive compensation, and equity incentive plan amendments.

Niagen Bioscience is asking stockholders to approve an amendment to its 2017 Equity Incentive Plan to increase the number of shares available for issuance by 4.75 million and to approve a new Employee Stock Purchase Plan.

ChromaDex Corporation will hold its annual shareholder meeting on June 20, 2024, to vote on director elections, auditor ratification, and executive compensation.

ChromaDex Corporation will hold its 2024 Annual Meeting of Stockholders on June 20, 2024, to vote on the election of directors, ratification of the independent auditor, and an advisory vote on executive compensation.